申请人:Andrews Steven W.
公开号:US20120178715A1
公开(公告)日:2012-07-12
Compounds of Formula I: and salts thereof in which R
1
, R
2
, R
2a
, R
3
, n, X and ring B have the meanings given in the specification, are inhibitors of mTOR and are useful in the treatment of diseases which are sensitive to inhibition of mTOR, such as cancers.
式I的化合物及其盐,其中R1、R2、R2a、R3、n、X和环B具有规范中所给出的含义,是mTOR的抑制剂,可用于治疗对mTOR抑制敏感的疾病,如癌症。